Dose-dependent subacute cardiovascular effects of modafinil in rats

References

• Aebi, H., 1984. Catalase in vitro. Methods in Enzymology, 105, 121–126.
   PubMed Web of Science ®Google Scholar
• Arslan AK, Yasar S, Colak C, Yologlu S. 2018. WSSPAS: web-based sample size & power analysis software [Software]. http://biostatapps.inonu.edu.tr/WSSPAS/. [Accessed 1 October 2018].
   Google Scholar
• Ballon, J.S., and Feifel, D., 2006. A systematic review of modafinil: potential clinical uses and mechanisms of action. The Journal of Clinical Psychiatry, 67 (4), 554–566.
   PubMed Web of Science ®Google Scholar
• Benrud-Larson, L. M., et al., 2002. Quality of life in patients with postural tachycardia syndrome. Mayo Clinic Proceedings, 77 (6), 531–537.
   PubMed Web of Science ®Google Scholar
• Cephalon, 2004. Provigil (modafinil) prescribing information. West Chester, PA: Cephalon, Inc.
   Google Scholar
• Chapman, J.L., et al., 2014. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial. Thorax, 69 (3), 274–279.
   PubMed Web of Science ®Google Scholar
• Çolak, C., and Parlakpınar, H., 2012. Hayvan deneyleri: in vivo denemelerin bildirimi: ARRIVE Kılavuzu-Derleme. Turgut Özal Tıp Merkezi Dergisi, 19 (2), 128–131.
   Google Scholar
• Committee for Medicinal Products for Human Use 2011. Assessment report for modafinil containing medicinal products. European Medicines Agency.
   Google Scholar
• Crabbe, J. B., et al. 2003. Modafinil does not affect heart rate or heart rate variability from 0800-1200 hours during 88 hours of simulated sustained operations. Sleep, 26, A173–A174.
   Google Scholar
• Darwish, M., et al., 2010. Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: a randomized, open-label, crossover study. Clinical Therapeutics, 32 (12), 2074–2087.
   PubMed Web of Science ®Google Scholar
• Dauvilliers, Y., et al.,; HARMONY I study group. 2013. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. The Lancet Neurology, 12 (11), 1068–1075.
   PubMed Web of Science ®Google Scholar
• Elovic, E., 2000. Use of provigil for underarousal following TBI. The Journal of Head Trauma Rehabilitation, 15 (4), 1068.
   PubMed Web of Science ®Google Scholar
• Esposito, R., et al., 2013. Acute effects of modafinil on brain resting state networks in young healthy subjects. PloS One, 8 (7), e69224.
   PubMed Web of Science ®Google Scholar
• Gilleen, J., et al., 2014. Modafinil combined with cognitive training is associated with improved learning in healthy volunteers-a randomised controlled trial. European Neuropsychopharmacology, 24 (4), 529–539.
   PubMed Web of Science ®Google Scholar
• Harris, C., 2016. The acute effects of modafinil on behavioural and ERP measures of attention. University of Tasmania.
   Google Scholar
• Heitmann, J., et al., 1999. Does short-term treatment with modafinil affect blood pressure in patients with obstructive sleep apnea? Clinical Pharmacology and Therapeutics, 65 (3), 328–335.
   PubMed Web of Science ®Google Scholar
• Jacobs, I., and Bell, D.G., 2004. Effects of acute modafinil ingestion on exercise time to exhaustion. Medicine and Science in Sports and Exercise, 36 (6), 1078–1082.
   PubMed Web of Science ®Google Scholar
• Kalkan, F., et al., 2018. Protective and therapeutic effects of dexpanthenol on isoproterenol-induced cardiac damage in rats. Journal of Cellular Biochemistry, 119 (9), 7479–7489.
   PubMed Web of Science ®Google Scholar
• Kesavulu, M.M., et al., 2001. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease. Diabetes Research and Clinical Practice, 53 (1), 33–39.
   PubMed Web of Science ®Google Scholar
• Kim, D., 2012. Practical use and risk of modafinil, a novel waking drug. Environmental Health and Toxicology, 27, e2012007.
   PubMedGoogle Scholar
• Kmecova, J., and Klimas, J., 2010. Heart rate correction of the QT duration in rats. European Journal of Pharmacology, 641 (2-3), 187–192.
   PubMed Web of Science ®Google Scholar
• Koivusalo, M., and Uotila, L., 1974. Enzymatic method for the quantitative determination of reduced glutathione. Analytical Biochemistry, 59 (1), 34–45.
   PubMed Web of Science ®Google Scholar
• Kpaeyeh, A.G., et al., 2014. Hemodynamic profiles and tolerability of modafinil in the treatment of postural tachycardia syndrome: a randomized, placebo-controlled trial. Journal of Clinical Psychopharmacology, 34 (6), 738–741.
   PubMed Web of Science ®Google Scholar
• Kumar, R., 2008. Approved and investigational uses of modafinil: an evidence-based review. Drugs, 68 (13), 1803–1839.
   PubMed Web of Science ®Google Scholar
• Lee, N., et al., 2013. A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes. Drug and Alcohol Review, 32 (1), 88–95.
   PubMed Web of Science ®Google Scholar
• Lynch, J., Jr., et al., 2009. Hemodynamic and cardiac neurotransmitter-releasing effects in conscious dogs of attention-and wake-promoting agents: a comparison of d-amphetamine, atomoxetine, modafinil, and a novel quinazolinone H3 inverse agonist. Journal of Cardiovascular Pharmacology, 53 (1), 52–59.
   PubMed Web of Science ®Google Scholar
• Madras, B.K., et al., 2006. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. The Journal of Pharmacology and Experimental Therapeutics, 319 (2), 561–569.
   PubMed Web of Science ®Google Scholar
• Makela, E. H., Miller, K., and Cutlip 2nd, W. D, 2003. Three case reports of modafinil use in treating sedation induced by antipsychotic medications. The Journal of Clinical Psychiatry, 64 (4), 485.
   Web of Science ®Google Scholar
• McCord, J.M., 1993. Human disease, free radicals, and the oxidant/antioxidant balance. Clinical Biochemistry, 26 (5), 351–357.
   PubMed Web of Science ®Google Scholar
• Mignot, E., et al., 1994. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep, 17 (5), 436–437.
   PubMed Web of Science ®Google Scholar
• Minzenberg, M. J., and Carter, C. S., 2008. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology, 33 (7), 1477–1502.
   PubMed Web of Science ®Google Scholar
• Mitler, M.M., et al., 1998. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Annals of Neurology, 43 (1), 88–97.
   PubMed Web of Science ®Google Scholar
• Morales, M., and Munne-Bosch, S., 2019. Malondialdehyde: facts and artifacts. Plant Physiology, 180 (3), 1246–1250.
   PubMed Web of Science ®Google Scholar
• Murphy, M.P., 2009. How mitochondria produce reactive oxygen species. The Biochemical Journal, 417 (1), 1–13. English.
   PubMed Web of Science ®Google Scholar
• Ornell, F., et al., 2014. Modafinil effects on behavior and oxidative damage parameters in brain of wistar rats. Behavioural Neurology, 2014, 917246
   PubMed Web of Science ®Google Scholar
• Parlakpinar, H., et al., 2019. Acute and subacute effects of low versus high doses of standardized Panax Ginseng extract on the heart: an experimental study. Cardiovascular Toxicology, 19 (4), 306–320.
   PubMed Web of Science ®Google Scholar
• Parlakpinar, H., Ozer, M.K., and Acet, A., 2005. Effect of aminoguanidine on ischemia-reperfusion induced myocardial injury in rats. Molecular and Cellular Biochemistry, 277 (1-2), 137–142.
   PubMed Web of Science ®Google Scholar
• Phaniendra, A., Jestadi, D.B., and Periyasamy, L., 2015. Free radicals: properties, sources, targets, and their implication in various diseases. Indian Journal of Clinical Biochemistry, 30 (1), 11–26.
   PubMed Web of Science ®Google Scholar
• Pierre, J. M., et al., 2007. A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophrenia. The Journal of Clinical Psychiatry, 68 (05), 705–710.
   PubMed Web of Science ®Google Scholar
• Robertson, P., and Hellriegel, E. T., 2003. Clinical pharmacokinetic profile of modafinil. Clinical Pharmacokinetics, 42 (2), 123–137.
   PubMed Web of Science ®Google Scholar
• Rossi, G.P., et al., 2011. Drug-related hypertension and resistance to antihypertensive treatment: a call for action. Journal of Hypertension, 29 (12), 2295–2309.
   PubMed Web of Science ®Google Scholar
• Schmidt, A., et al., 2018. Acute effects of methylphenidate, modafinil, and MDMA on negative emotion processing. The International Journal of Neuropsychopharmacology, 21 (4), 345–354.
   PubMed Web of Science ®Google Scholar
• Sun, Y., Oberley, L.W., and Li, Y., 1988. A simple method for clinical assay of superoxide dismutase. Clinical Chemistry, 34 (3), 497–500.
   PubMed Web of Science ®Google Scholar
• Taneja, I., et al., 2005. Modafinil elicits sympathomedullary activation. Hypertension, 45 (4), 612–618.
   PubMed Web of Science ®Google Scholar
• Uchiyama, M., and Mihara, M., 1978. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry, 86 (1), 271–278.
   PubMed Web of Science ®Google Scholar
• Volkow, N.D., et al., 2009. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA, 301 (11), 1148–1154.
   PubMed Web of Science ®Google Scholar
• Walker, M.J., et al., 1988. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovascular Research, 22 (7), 447–455.
   PubMed Web of Science ®Google Scholar
• Yasmeen Muhialdeen, H., Jawad, A.H., and Al-Hashemi, W.K.H. 2015. Study of some markers of oxidative stress statues in cardiovascular disease patients. Journal of Al-Nahrain University Science, 18 (3), 38–43.
   Google Scholar